The global machine learning in pharmaceutical industry market is predicted to grow at a tremendous CAGR of 37.9%, thereby garnering a revenue of $26,151.8 million in the 2022-2031 timeframe. This report provides an overview of the market including its main characteristics like growth drivers, growth opportunities, restraints, and hindrances in the 2022-2031 timeframe. The report also contains all the necessary and essential market figures to help new entrants gain an insight into the nature and working of the market. The primary growth driver of the machine learning in pharmaceutical industry market in the forecast period is the growing demand for personalized treatment/behavioral modification. Additionally, increasing adoption of machine learning to accelerate the drug discovery process is expected to help the market grow in the forecast period.
